Johnson // Becker
Uloric lawsuits being filed is a medication used to treat gout that recently received a boxed warning from the FDA due to an increased risk of heart-related death.
Xeljanz (tofacitinib) was found to increase a risk of blood clots in the lungs or death during a postmarketing study of the medication.
Patients taking Viberzi to treat irritable bowel syndrome may be at risk of suffering from pancreatitis, which could lead to hospitalization or death.
Many patients are at risk of fatal side effects from taking Actemra, despite marketing efforts by its manufacturer that claim otherwise.
The FDA identified that certain type-2 diabetes medications may trigger the onset of a flesh-eating infection known as Fournier’s gangrene.
Valsartan is a blood pressure medication that was recalled due to the presence of a carcinogenic ingredient patients were not aware of until this year.
A medication used to treat relapsing multiple sclerosis, Gilenya, poses a threat to patients as symptoms may worsen if they discontinue use.
Learn more about the recent FDA “Black Box Warning” on popular multiple sclerosis (MS) and B-cell chronic lymphocytic leukemia (B-CLL) drugs that have been linked to arterial dissection and strokes.
Montelukast sodium tablets were voluntarily recalled because they were mixed up with another medication which could cause injury to an unsuspecting patient.
Consumers were warned by the U.S. Food and Drug Administration (FDA) to immediately stop using benzocaine teething products such as Orajel for babies as it can cause a rare but serious form of methemoglobinemia.